e-learning
resources
Virtual 2021
06.09.2021
Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients
C. Aloe (Bundoora, Australia), P. Papagianis (Bundoora, Australia), J. Mcqualter (Bundoora, Australia), C. Mcdonald (Heidelberg, Australia), T. Leong (Heidelberg, Australia), N. Goh (Heidelberg, Australia), S. Bozinovski (Bundoora, Australia)
Source:
Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Session:
Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Session type:
E-poster
Number:
2255
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Aloe (Bundoora, Australia), P. Papagianis (Bundoora, Australia), J. Mcqualter (Bundoora, Australia), C. Mcdonald (Heidelberg, Australia), T. Leong (Heidelberg, Australia), N. Goh (Heidelberg, Australia), S. Bozinovski (Bundoora, Australia). Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients. 2255
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Late Breaking Abstract - Protein signature stratifies severity of chronic lung disease in preterms after birth
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017
Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Late Breaking Abstract - Asthma control in preschool and subsequent disease remission
Source: International Congress 2019 – Asthma and the world
Year: 2019
Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021
Late Breaking Abstract - Impact of increasing notification thresholds for remote respiratory monitoring in patients with chronic lung disease
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
Late Breaking Abstract - Usefulness of lung ultrasound in the diagnosis and early detection of acute chest syndrome in children with sickle cell disease
Source: Virtual Congress 2021 – Thoracic ultrasound as a bedside clinical tool
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept